$BCRX my only concern is over a year out. the pumpy guru’s aren’t the right guys to field this question either for obvious reasons but I’ll chum the waters…. how much market share can a slightly less effective drug than 9930 take in pnh. with a 6 month+ head start to market keep in mind the other drug also eliminates blood transfusions, of course there’s always room for two companies in the space, stonehouse words not mine. but who wants to share market and how much will competitor claim with a head start just know I’ll be at OPW headquarters meditating on this for the next few months
7
7
7 Likes